We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan Requests Review of Two Patents for Sanofi’s Lantus Insulin
Mylan Requests Review of Two Patents for Sanofi’s Lantus Insulin
Mylan challenged two patents on Sanofi’s insulin glargine formulation, Lantus, and is requesting an inter partes review by the PTO’s Patent and Trial Appeal Board.
